πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7662999

Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors

The United States of America as represented by the Department of Health and Human Services (DHHS) Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662619

Sol-fusin: use of GP64-6His to catalyze membrane fusion

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662592

Bacteriocin inducer peptides

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662573

Methods for evaluating osteoarthritis risk

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662568

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662397

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662394

Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659081

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659115

Nucleic acid encoding human transductin-1 polypeptide

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7658364

Ocular therapeutic agent delivery devices and methods for making and using such devices

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655397

Selections of genes and methods of using the same for diagnosis and for targeting the ther

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655752

TNF-Ξ± converting enzyme inhibitory agents and method of using same

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655694

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655474

Trioxyethylene gold nanoclusters functionalized with a single DNA

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655247

Malaria vaccines

The Government of the United States, as Respresented by the Secretary of the Army Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7649028

Interim dental dressing and restorative material

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7648701

Peptide composition as immunogen for the treatment of allergy

United Biomedical, Inc. Β· Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7641909

Avirulent, immunogenic flavivirus chimeras

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7641906

Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus i

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638333

Anthrax vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638130

Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638134

Insertion sites in fowlpox vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635486

Recombinant lipidated PsaA protein, methods of preparation and use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635688

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted